IDENTIFICATION OF PROTEINS THAT STRUCTURE THE ENDOPLASMIC RETICULUM

构建内质网的蛋白质的鉴定

基本信息

  • 批准号:
    7873521
  • 负责人:
  • 金额:
    $ 13.38万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-06-01 至 2012-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The endoplasmic reticulum (ER) is a continuous membrane network of flat sheets and curved tubules. The network plays a central role in a variety of processes critical for human health, ranging from lipid and protein synthesis and transport, to calcium homeostasis. Segregation of certain ER processes into rough and smooth sub-domains as well as the striking differences in the morphology and organization of ER membranes in specialized cell types are suggestive of a link between organelle form and function. Yet a clear understanding of the mechanisms generating and maintaining the sub-compartmentalized tubular and cisternal membrane network of the ER is lacking. Our long-term objective is to define the molecular underpinnings and functional roles for the distinct structural features of the mammalian ER. The first step in achieving this goal is identification of the proteins that govern ER morphology. Although a number of candidates likely to participate in ER structuring have been identified, few have been shown to be required in living cells. To facilitate the search for the required proteins, a candidate-based morphological RNAi screen in cultured cells has been initiated. A recently published early secretory pathway proteome of 1430 constituents (Gilchrist et al, 2006, Cell 127:1265-1281) has been pared down to a candidate pool of 117 proteins, the majority of which are previously uncharacterized. The screen is proving effective, as it has already yielded two hits and preliminary analysis of the first is confirming its role in regulating ER structure. The primary objective of this exploratory proposal is to continue the screen to identify new ER structure regulators. Each hit to emerge from the screen will be confirmed by testing whether expression of an RNAi-immune construct coding for the targeted protein rescues the RNAi-induced ER morphological abnormalities. Once hits are validated, site-directed mutagenesis, protein interaction assays, and phenotypic analysis aided by high-resolution imaging will enable identification of the structural determinants and binding partners required for the ability of each newly identified protein to perform its organelle structuring function. Preliminary studies on the first confirmed hit to emerge from the screen have identified both a critical amino acid residue in the ER structure regulator and a likely binding partner required to mediate its function. The completion of the proposed screen and preliminary analysis of the proteins identified under this exploratory award promises to yield novel insights into the mechanisms that generate ER network architecture. Ultimately, an understanding of the functional consequences of the RNAi-induced structural deficits or rearrangements identified through the screen may lead to novel therapeutics in the treatment of diseases that stem from ER dysfunction. PUBLIC HEALTH RELEVANCE: The endoplasmic reticulum (ER) carries out a myriad of processes critical to human health and disease. It is the site of drug detoxification; lipid and protein biosynthesis and trafficking; protein folding and quality control; and calcium signaling. The functional importance of the organelle in all tissues is clear. Moreover the striking differences in the architecture and organization of the ER membrane network in specialized cells types have led to the long-standing notion that the structure and sub-compartmentalization of the organelle are critical for its functions. Yet the mechanisms that structure the ER and the exact relationship between organelle structure and function are only poorly understood. The objective of this proposal is to identify novel mammalian proteins that govern ER structure. The results are expected to lead to a fuller understanding of the structure-function relationship of the organelle. Ultimately, it is hoped that the insights gained will aid in the development of therapeutics for the treatment of diseases that stem from ER dysfunction.
DESCRIPTION (provided by applicant): The endoplasmic reticulum (ER) is a continuous membrane network of flat sheets and curved tubules. The network plays a central role in a variety of processes critical for human health, ranging from lipid and protein synthesis and transport, to calcium homeostasis. Segregation of certain ER processes into rough and smooth sub-domains as well as the striking differences in the morphology and organization of ER membranes in specialized cell types are suggestive of a link between organelle form and function. Yet a clear understanding of the mechanisms generating and maintaining the sub-compartmentalized tubular and cisternal membrane network of the ER is lacking. Our long-term objective is to define the molecular underpinnings and functional roles for the distinct structural features of the mammalian ER. The first step in achieving this goal is identification of the proteins that govern ER morphology. Although a number of candidates likely to participate in ER structuring have been identified, few have been shown to be required in living cells. To facilitate the search for the required proteins, a candidate-based morphological RNAi screen in cultured cells has been initiated. A recently published early secretory pathway proteome of 1430 constituents (Gilchrist et al, 2006, Cell 127:1265-1281) has been pared down to a candidate pool of 117 proteins, the majority of which are previously uncharacterized. The screen is proving effective, as it has already yielded two hits and preliminary analysis of the first is confirming its role in regulating ER structure. The primary objective of this exploratory proposal is to continue the screen to identify new ER structure regulators. Each hit to emerge from the screen will be confirmed by testing whether expression of an RNAi-immune construct coding for the targeted protein rescues the RNAi-induced ER morphological abnormalities. Once hits are validated, site-directed mutagenesis, protein interaction assays, and phenotypic analysis aided by high-resolution imaging will enable identification of the structural determinants and binding partners required for the ability of each newly identified protein to perform its organelle structuring function. Preliminary studies on the first confirmed hit to emerge from the screen have identified both a critical amino acid residue in the ER structure regulator and a likely binding partner required to mediate its function. The completion of the proposed screen and preliminary analysis of the proteins identified under this exploratory award promises to yield novel insights into the mechanisms that generate ER network architecture. Ultimately, an understanding of the functional consequences of the RNAi-induced structural deficits or rearrangements identified through the screen may lead to novel therapeutics in the treatment of diseases that stem from ER dysfunction. PUBLIC HEALTH RELEVANCE: The endoplasmic reticulum (ER) carries out a myriad of processes critical to human health and disease. It is the site of drug detoxification; lipid and protein biosynthesis and trafficking; protein folding and quality control; and calcium signaling. The functional importance of the organelle in all tissues is clear. Moreover the striking differences in the architecture and organization of the ER membrane network in specialized cells types have led to the long-standing notion that the structure and sub-compartmentalization of the organelle are critical for its functions. Yet the mechanisms that structure the ER and the exact relationship between organelle structure and function are only poorly understood. The objective of this proposal is to identify novel mammalian proteins that govern ER structure. The results are expected to lead to a fuller understanding of the structure-function relationship of the organelle. Ultimately, it is hoped that the insights gained will aid in the development of therapeutics for the treatment of diseases that stem from ER dysfunction.

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Christina H Lee其他文献

Christina H Lee的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Christina H Lee', 18)}}的其他基金

Mechanism and Role of Membrane Fusion by the Atlastin GTPase
Atlastin GTPase 膜融合的机制和作用
  • 批准号:
    10436798
  • 财政年份:
    2014
  • 资助金额:
    $ 13.38万
  • 项目类别:
Mechanism and Role of Membrane Fusion by the Atlastin GTPase
Atlastin GTPase 膜融合的机制和作用
  • 批准号:
    10630357
  • 财政年份:
    2014
  • 资助金额:
    $ 13.38万
  • 项目类别:
Mechanism and Role of Membrane Fusion by the Atlastin GTPase - Equipment Supplement
Atlastin GTPase 膜融合的机制和作用 - 设备补充
  • 批准号:
    10581823
  • 财政年份:
    2014
  • 资助金额:
    $ 13.38万
  • 项目类别:
Mechanism and role of membrane fusion by the atlastin GTPase
atlastin GTPase 膜融合的机制和作用
  • 批准号:
    9071876
  • 财政年份:
    2014
  • 资助金额:
    $ 13.38万
  • 项目类别:
Mechanism and role of membrane fusion by the atlastin GTPase
atlastin GTPase 膜融合的机制和作用
  • 批准号:
    8760551
  • 财政年份:
    2014
  • 资助金额:
    $ 13.38万
  • 项目类别:
Mechanism and role of membrane fusion by the atlastin GTPase
atlastin GTPase 膜融合的机制和作用
  • 批准号:
    9314318
  • 财政年份:
    2014
  • 资助金额:
    $ 13.38万
  • 项目类别:
IDENTIFICATION OF PROTEINS THAT STRUCTURE THE ENDOPLASMIC RETICULUM
构建内质网的蛋白质的鉴定
  • 批准号:
    8049736
  • 财政年份:
    2010
  • 资助金额:
    $ 13.38万
  • 项目类别:

相似海外基金

Double Incorporation of Non-Canonical Amino Acids in an Animal and its Application for Precise and Independent Optical Control of Two Target Genes
动物体内非规范氨基酸的双重掺入及其在两个靶基因精确独立光学控制中的应用
  • 批准号:
    BB/Y006380/1
  • 财政年份:
    2024
  • 资助金额:
    $ 13.38万
  • 项目类别:
    Research Grant
Quantifying L-amino acids in Ryugu to constrain the source of L-amino acids in life on Earth
量化 Ryugu 中的 L-氨基酸以限制地球生命中 L-氨基酸的来源
  • 批准号:
    24K17112
  • 财政年份:
    2024
  • 资助金额:
    $ 13.38万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Molecular recognition and enantioselective reaction of amino acids
氨基酸的分子识别和对映选择性反应
  • 批准号:
    23K04668
  • 财政年份:
    2023
  • 资助金额:
    $ 13.38万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Basic research toward therapeutic strategies for stress-induced chronic pain with non-natural amino acids
非天然氨基酸治疗应激性慢性疼痛策略的基础研究
  • 批准号:
    23K06918
  • 财政年份:
    2023
  • 资助金额:
    $ 13.38万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular mechanisms how arrestins that modulate localization of glucose transporters are phosphorylated in response to amino acids
调节葡萄糖转运蛋白定位的抑制蛋白如何响应氨基酸而被磷酸化的分子机制
  • 批准号:
    23K05758
  • 财政年份:
    2023
  • 资助金额:
    $ 13.38万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Design and Synthesis of Fluorescent Amino Acids: Novel Tools for Biological Imaging
荧光氨基酸的设计与合成:生物成像的新工具
  • 批准号:
    2888395
  • 财政年份:
    2023
  • 资助金额:
    $ 13.38万
  • 项目类别:
    Studentship
Collaborative Research: RUI: Elucidating Design Rules for non-NRPS Incorporation of Amino Acids on Polyketide Scaffolds
合作研究:RUI:阐明聚酮化合物支架上非 NRPS 氨基酸掺入的设计规则
  • 批准号:
    2300890
  • 财政年份:
    2023
  • 资助金额:
    $ 13.38万
  • 项目类别:
    Continuing Grant
Structurally engineered N-acyl amino acids for the treatment of NASH
用于治疗 NASH 的结构工程 N-酰基氨基酸
  • 批准号:
    10761044
  • 财政年份:
    2023
  • 资助金额:
    $ 13.38万
  • 项目类别:
Lifestyle, branched-chain amino acids, and cardiovascular risk factors: a randomized trial
生活方式、支链氨基酸和心血管危险因素:一项随机试验
  • 批准号:
    10728925
  • 财政年份:
    2023
  • 资助金额:
    $ 13.38万
  • 项目类别:
Single-molecule protein sequencing by barcoding of N-terminal amino acids
通过 N 端氨基酸条形码进行单分子蛋白质测序
  • 批准号:
    10757309
  • 财政年份:
    2023
  • 资助金额:
    $ 13.38万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了